INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
about
INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@en
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@nl
type
label
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@en
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@nl
prefLabel
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@en
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@nl
P2093
P2860
P1476
INCIDENCE OF TUBERCULOSIS AMON ...... ERON AND RIBAVIRIN IN GEORGIA.
@en
P2093
A Abutidze
L Sharvadze
N Bolokadze
T Tsertsvadze
P2860
P577
2016-03-01T00:00:00Z